Mouse models of human diseases are invaluable tools for studying pathogenic mechanisms
and testing interventions and therapeutics. For disorders such as Alzheimer’s disease in …

Rapid diagnostic tests (RDTs) for SARS-CoV-2 antigens (Ag) that can be performed at point
of care (POC) can supplement molecular testing and help mitigate the COVID-19 pandemic. …

Animal models of disease are valuable resources for investigating pathogenic mechanisms
and potential therapeutic interventions. However, for complex disorders such as Alzheimer’s …

Background The TREM2 R47H variant is one of the strongest genetic risk factors for late-onset
Alzheimer’s Disease (AD). Unfortunately, many current Trem2 R47H mouse models are …

The majority of Alzheimer’s disease (AD) cases are late-onset and occur sporadically, however
most mouse models of the disease harbor pathogenic mutations, rendering them better …

Background To facilitate deployment of point-of-care testing for severe acute respiratory
syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high…

Objective To assess knowledge, attitudes, and practices (KAP) related to antimicrobial
resistance (AMR) among college students. Participants Undergraduate students at a large public …

Background Genome‐Wide Association Studies revealed Triggering receptor expressed on
myeloid cells 2 (TREM2) R47H mutation as one of the strongest genetic risk factors for late‐…

In galaxy clusters, the intracluster medium (ICM) is expected to host a diffuse, long-lived, and
invisible population of" fossil" cosmic-ray electrons (CRe) with 1–100 MeV energies. These …

Background Genome‐Wide Association Studies (GWAS) implicate clusterin (CLU, also
known as apolipoprotein J) as a risk factor for late‐onset Alzheimer's disease (LOAD), with …